Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3.

Evans syndrome SASH3 deficiency autoimmune cytopenias inborn errors of immunity whole exome sequencing

Journal

British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544

Informations de publication

Date de publication:
11 2023
Historique:
revised: 09 08 2023
received: 23 04 2023
accepted: 11 08 2023
medline: 15 11 2023
pubmed: 30 8 2023
entrez: 30 8 2023
Statut: ppublish

Résumé

Increasing evidence suggests multilineage cytopenias (also known as Evans syndrome) may be caused by inborn errors of immunity (IEI) with immune dysregulation. We studied a patient with autoimmune haemolytic anaemia and immune thrombocytopenia and identified a germline mutation in SASH3 (c.862C>T;p.Arg288Ter), indicating a recently identified IEI. Immunohistochemistry performed after clinically indicated splenectomy revealed severe hypoplasia/absence of germinal centres. The autoimmune phenotype was associated with an increased CD21

Identifiants

pubmed: 37646304
doi: 10.1111/bjh.19061
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

678-683

Informations de copyright

© 2023 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.

Références

Schifferli A, Cavalli F, Godeau B, Liebman HA, Recher M, Imbach P, et al. Understanding immune thrombocytopenia: looking out of the box. Front Med (Lausanne). 2021;8:613192.
Barcellini W, Fattizzo B. The changing landscape of autoimmune hemolytic anemia. Front Immunol. 2020;11:946.
Cornelissen HM, Musekwa EM, Glashoff RH, Esser M, Zunza M, Abraham DR, et al. Peripheral-blood cytopenia, an early indicator of inborn errors of immunity. Br J Haematol. 2022;198:875-886.
Westermann-Clark E, Meehan CA, Meyer AK, Dasso JF, Amre D, Ellison M, et al. Primary immunodeficiency in children with autoimmune cytopenias: retrospective 154-patient cohort. Front Immunol. 2021;12:649182.
Fischer A, Provot J, Jais J-P, Alcais A, Mahlaoui N; members of the CEREDIH French PID study group. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2017;140:1388-1393.e8.
Hadjadj J, Aladjidi N, Fernandes H, Leverger G, Magérus-Chatinet A, Mazerolles F, et al. Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood. 2019;134:9-21.
Kumar D, Prince C, Bennett CM, Briones M, Lucas L, Russell A, et al. T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome. Blood. 2022;139:369-383.
Keller B, Warnatz K. T-bethighCD21low B cells: the need to unify our understanding of a distinct B cell population in health and disease. Curr Opin Immunol. 2023;82:102300.
Delmonte OM, Bergerson JRE, Kawai T, Kuehn HS, McDermott DH, Cortese I, et al. SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation. Blood. 2021;138:1019-1033.
Labrador-Horrillo M, Franco-Jarava C, Garcia-Prat M, Parra-Martínez A, Antolín M, Salgado-Perandrés S, et al. Case report: X-linked SASH3 deficiency presenting as a common variable immunodeficiency. Front Immunol. 2022;13:881206.
Reis B, Pfeffer K, Beer-Hammer S. The orphan adapter protein SLY1 as a novel anti-apoptotic protein required for thymocyte development. BMC Immunol. 2009;10:38.
Beer S, Scheikl T, Reis B, Hüser N, Pfeffer K, Holzmann B. Impaired immune responses and prolonged allograft survival in Sly1 mutant mice. Mol Cell Biol. 2005;25:9646-9660.
Salzer E, Cagdas D, Hons M, Mace EM, Garncarz W, Petronczki ÖY, et al. RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics. Nat Immunol. 2016;17:1352-1360.
Kratzer B, Trapin D, Ettel P, Körmöczi U, Rottal A, Tuppy F, et al. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations. Allergy. 2021;76:751-765.
Pincez T, Aladjidi N, Héritier S, Garnier N, Fahd M, Abou Chahla W, et al. Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias. Blood. 2022;140:253-261.

Auteurs

Wolfgang Novak (W)

St. Anna Children's Hospital, Vienna, Austria.
Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Vienna, Austria.

Jakob Berner (J)

St. Anna Children's Hospital, Vienna, Austria.
Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Vienna, Austria.
St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Department of Dermatology, Venerology and Allergology, Klinik Landstrasse, Vienna, Austria.

Michael Svaton (M)

St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Raul Jimenez-Heredia (R)

St. Anna Children's Hospital, Vienna, Austria.
Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Vienna, Austria.
St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.

Anna Segarra-Roca (A)

St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.

Alexandra Frohne (A)

St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.

Sarah Guiliani (S)

St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.

David Rouhani (D)

St. Anna Children's Hospital, Vienna, Austria.
Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Vienna, Austria.

Sebastian K Eder (SK)

St. Anna Children's Hospital, Vienna, Austria.
Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Vienna, Austria.
St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.

Arno Rottal (A)

Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Vienna, Austria.

Doris Trapin (D)

Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Vienna, Austria.

Anja Scheuchenstuhl (A)

Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Vienna, Austria.

Winfried F Pickl (WF)

Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Vienna, Austria.

Ingrid Simonitsch-Klupp (I)

Medical University of Vienna, Clinical Institute of Pathology, Vienna, Austria.

Leo Kager (L)

St. Anna Children's Hospital, Vienna, Austria.
Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Vienna, Austria.
St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.

Kaan Boztug (K)

St. Anna Children's Hospital, Vienna, Austria.
Medical University of Vienna, Department of Pediatrics and Adolescent Medicine, Vienna, Austria.
St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH